Estados Unidos · Bolsa y Finanzas · MarketWatch

Zealand Pharma Shares Drop After Boehringer Obesity Drug Trial Results

Publicado por MarketWatch · Estados Unidos hace 10 h

Zealand Pharma shares fell after German partner Boehringer Ingelheim reported results from a late-stage clinical trial of an obesity drug candidate licensed from the Danish…

Leer el artículo completo en MarketWatch Inicie sesión para guardar

MediaNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.marketwatch.com)

Zealand Pharma Shares Drop After Boehringer Obesity Drug Trial Results

También te puede interesar

McGraw Hill cuts another $50M of debt, targets 2-2.5x leverage

Senate Democrats are questioning the legality of the Pentagon's Venezuela oil deal

Indian Refiners Seek Tankers for Hormuz Oil

Morning Minute: Crypto Gives Up on Congress and Goes After Senators

New York Times Reporting Through a Front Page That Never Published and More

Satlyt, founded by a former Google and SpaceX product manager, raises $8M to run AI on satellites

Zealand Pharma Shares Drop After Boehringer Obesity Drug Trial Results

Compartir

También te puede interesar

McGraw Hill cuts another $50M of debt, targets 2-2.5x leverage

Senate Democrats are questioning the legality of the Pentagon's Venezuela oil deal

Indian Refiners Seek Tankers for Hormuz Oil

Morning Minute: Crypto Gives Up on Congress and Goes After Senators

New York Times Reporting Through a Front Page That Never Published and More

Satlyt, founded by a former Google and SpaceX product manager, raises $8M to run AI on satellites